Authors:
Ruschitzka, F
Quaschning, T
Noll, G
deGottardi, A
Rossier, MF
Enseleit, F
Hurlimann, D
Luscher, TF
Shaw, SG
Citation: F. Ruschitzka et al., Endothelin 1 type A receptor antagonism prevents vascular dysfunction and hypertension induced by 11 beta-hydroxysteroid dehydrogenase inhibition - Role of nitric oxide, CIRCULATION, 103(25), 2001, pp. 3129-3135
Authors:
Klainguti, M
Aigner, S
Kilo, J
Eppenberger, HM
Mandinova, A
Aebi, U
Schaub, MC
Shaw, SG
Luscher, TF
Atar, D
Citation: M. Klainguti et al., Lack of nuclear apoptosis in cardiomyocytes and increased endothelin-1 levels in a rat heart model of myocardial stunning, BAS R CARD, 95(4), 2000, pp. 308-315
Citation: M. Burkhardt et al., Receptor- and non-receptor-mediated clearance of big-endothelin and endothelin-1: differential effects of acute and chronic ETA receptor blockade, J HYPERTENS, 18(3), 2000, pp. 273-279
Citation: Sg. Shaw et al., Critical factors in the radioimmunoassay of endothelin-1, endothelin-3, and big endothelin-1 in human plasma, ANALYT BIOC, 278(2), 2000, pp. 143-149
Authors:
Lanza, GA
Luscher, TF
Pasceri, V
Shaw, SG
Buffon, A
Montenero, AS
Crea, F
Maseri, A
Citation: Ga. Lanza et al., Effects of atrial pacing on arterial and coronary sinus endothelin-1 levels in syndrome X, AM J CARD, 84(10), 1999, pp. 1187-1191